Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors [Phase 3]
A Phase 3 trial evaluating high-dose I-131 MIBG for metastatic neuroendocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion [Phase 3]
A Phase 3 clinical trial evaluating the effect of oral 5-HTP on urinary 5-HIAA excretion was terminated.
-
CLINICAL_TRIALS trial_result · 2017-12-27Clinical Trial Update: AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial of AMG 479 in advanced carcinoid tumors and pancreatic neuroendocrine tumors has completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours [Phase 3]
Phase 3 trial comparing 177Lu-DOTA0-Tyr3-Octreotate with Octreotide LAR in inoperable, progressive somatostatin receptor–positive midgut car…
-
CLINICAL_TRIALS trial_result · 2017-08-04Clinical Trial Update: PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation
This report summarizes PET-CT imaging findings and preliminary clinical observations from a completed trial involving patients with neuroend…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Evaluation of Blood Vessel Formation in Endocrine Tumors
The National Cancer Institute-sponsored trial evaluating angiogenesis in endocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: 68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs) [Phase 1]
A Phase 1 trial evaluating the PET imaging agent 68Ga-DOTATOC for somatostatin receptor–positive neuroendocrine tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Best Therapy for Patients With Neuroendocrine Tumors
A clinical trial evaluating therapies for neuroendocrine tumors has completed enrollment; results are not provided in the snippet.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: EPO906 in Carcinoid and Other Neuroendocrine Tumors [Phase 2]
Phase 2 trial of EPO906 (irofulven) in carcinoid tumors and other neuroendocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin) [Phase 3]
Phase 3 trial comparing everolimus plus best supportive care to placebo plus best supportive care in patients with advanced neuroendocrine t…
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors [Phase 1]
A Phase 1 trial assessing the combination of pasireotide and RAD001 (everolimus) in patients with advanced neuroendocrine tumors has complet…
-
CLINICAL_TRIALS trial_result · 2016-06-13Clinical Trial Update: Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors [Phase 1]
A Phase 1 trial evaluating the combination of temsirolimus and vinorelbine ditartrate in adults with unresectable or metastatic solid tumors…
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial evaluating the use of combination chemotherapy as first-line therapy for locally advanced or metastatic neuroendocrine tumors …
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor [Phase 3]
Phase 3 trial update studying octreotide acetate with interferon alfa-2b or bevacizumab in metastatic or locally advanced high-risk neuroend…
-
CLINICAL_TRIALS trial_result · 2015-12-29Clinical Trial Update: Study of Pazopanib Monotherapy in Patients With Unresectable, Metastatic Neuroendocrine Tumor [Phase 2]
Phase 2 study of pazopanib monotherapy in patients with unresectable, metastatic neuroendocrine tumor has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET) [Phase 2]
Phase 2 clinical trial of MK-0646 in metastatic neuroendocrine tumors has completed and results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating sorafenib tosylate in patients with progressive metastatic neuroendocrine tumors has completed; results were posted…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers [Phase 1, Phase 2]
This trial update reports termination of the Phase 1/2 study of JI-101 in advanced low-grade endocrine tumors, ovarian cancer, and KRAS-muta…
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors [Phase 1]
Phase 1 trial update of sorafenib in combination with RAD001 (everolimus) in patients with advanced neuroendocrine tumors, including carcino…
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features [Phase 1]
Phase 1 clinical trial update for Seneca Valley Virus-001 with Cyclophosphamide in pediatric patients with relapsed/refractory neuroblastoma…
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating 68Ga-DOTATATE PET imaging in patients with neuroendocrine tumors to assess diagnostic performance.
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors [Phase 2]
Phase II trial results for a capecitabine, oxaliplatin, and bevacizumab regimen in metastatic/unresectable neuroendocrine tumors were posted…
-
CLINICAL_TRIALS trial_result · 2013-08-29Clinical Trial Update: 124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors. [Phase 2]
This entry describes a Phase 2 clinical trial evaluating 124I-MIBG tracer for assessing myocardial sympathetic denervation and imaging neuro…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples [NA]
Completed clinical trial evaluating methods for determining Chromogranin A in routine blood samples in patients with neuroendocrine tumors (…
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG [Phase 1]
Phase I trial evaluating safety, distribution, and radiation dosimetry of ultratrace iobenguane I-123 (MIBG); the study in neuroendocrine tu…